MétaCan
← tous les travaux

RETRACTED: The Use of DeepQSAR Models for the Discovery of Peptides with Enhanced Antimicrobial and Antibiofilm Potential

2025· article· en· 1 citations· W4415959751 sur OpenAlex· 10.1021/acs.jcim.5c02138

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Affiliation canadienneUne personne signataire a déclaré un établissement canadien. C'est la seule voie dont dispose la base habituelle.
Organisme subventionnaire canadienUn organisme canadien l'a financé. Le travail peut ne porter aucune affiliation canadienne.

Dossier post-publication

OpenAlex signale ce travail comme rétracté, mais aucune notice correspondante de Retraction Watch ne figure dans cette base.

Résumé

Increasing concerns regarding prolonged antibiotic usage have spurred the search for alternative treatments. Antimicrobial peptides (AMPs), first discovered in the 1980s, have exhibited significant potential against a broad range of bacteria. Short-sequenced AMPs are abundant in nature and present across various organisms. Recently, machine learning technologies, such as Quantitative Structure-Activity Relationships (QSAR), have enabled the expedited discovery of potential AMPs with broad-spectrum antibacterial activity as the amount of available AMP training data increases. Among these, Deep QSAR has recently emerged as a distinct type of application that utilizes conventional molecular descriptors in conjunction with more powerful deep learning (DL) models. Here, we demonstrate the power of Deep QSAR in predicting broad-spectrum AMP activity. Using a recurrent neural network-based QSAR model, we achieved nearly 90% 5-fold cross-validated accuracy in classifying AMP activity. Using the developed approach, we designed 100 novel peptides, of which 44 experimentally demonstrated more effective antibiofilm activity, and 31 peptides exhibited stronger antimicrobial activity compared to the well-characterized host defense peptide IDR-1018, which was demonstrated to possess broad-spectrum antibiofilm activity against a wide range of bacterial pathogens. . Additionally, a previous computer-aided peptide design study employing IDR-1018 derivatives successfully identified novel peptides with enhanced antibiofilm activity. Notably, 29 of these peptides demonstrated improvements of both antimicrobial and, particularly, antibiofilm properties, making them suitable prototypes for preclinical development and demonstrating the efficacy of DeepQSAR modeling in identifying novel and potent AMPs.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

La notice

Revue
Journal of Chemical Information and Modeling
Thématique
Antimicrobial Peptides and Activities
Domaine
Immunology and Microbiology
Établissements canadiens
Institute of Infection and ImmunityUniversity of OttawaUniversity of British Columbia
Organismes subventionnaires
British Columbia Knowledge Development FundNatural Sciences and Engineering Research Council of CanadaCanada Research ChairsCanada Foundation for Innovation
Mots-clés
Quantitative structure–activity relationshipAntimicrobialAntimicrobial peptidesPeptideDrug discoveryTraining set
Résumé présent dans OpenAlex
oui